The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) will be organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (SFD), on behalf of the European Federation for Medicinal Chemistry (EFMC).
The EFMC is the main organisation for European Medicinal Chemistry community, with 27 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally around 1200 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Belgium (Brussels, 2010), Germany (Berlin, 2012), Portugal (Lisbon, 2014) and most recently in the United Kingdom (Manchester, 2016).
The 2018 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.
More information can be found on the website.
